RUBINSTEIN JULIE
Reporting owner on Forms 3, 4 and 5, CIK 1780664.
RUBINSTEIN JULIE reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-10-08.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ADPT · Adaptive Biotechnologies CorpCIK 1478320 | officer (President and COO) | 2 | 2026-10-08 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ADPT · Adaptive Biotechnologies Co…Common Stock | 2026-10-08 | M exercised | +11,881 | $12.14 | 389,683 | Form 4 |
| ADPT · Adaptive Biotechnologies Co…Common Stock | 2026-10-08 | S sold | -11,881 | $25.66 | 377,802 | Form 4 |
| ADPT · Adaptive Biotechnologies Co…Stock Option (right to buy), derivative | 2026-10-08 | M exercised | -11,881 | $0 | 308,491 | Form 4 |
| ADPT · Adaptive Biotechnologies Co…Common Stock | 2026-10-07 | M exercised | +11,881 | $12.14 | 389,683 | Form 4 |
| ADPT · Adaptive Biotechnologies Co…Common Stock | 2026-10-07 | S sold | -11,881 | $26.4 | 377,802 | Form 4 |
| ADPT · Adaptive Biotechnologies Co…Stock Option (right to buy), derivative | 2026-10-07 | M exercised | -11,881 | $0 | 320,372 | Form 4 |
| ADPT · Adaptive Biotechnologies Co…Common Stock | 2026-10-06 | M exercised | +11,881 | $12.14 | 389,683 | Form 4 |
| ADPT · Adaptive Biotechnologies Co…Common Stock | 2026-10-06 | S sold | -9,381 | $27.36 | 380,302 | Form 4 |
| ADPT · Adaptive Biotechnologies Co…Common Stock | 2026-10-06 | S sold | -1,100 | $28.21 | 379,202 | Form 4 |
| ADPT · Adaptive Biotechnologies Co…Common Stock | 2026-10-06 | S sold | -901 | $29.71 | 378,301 | Form 4 |
| ADPT · Adaptive Biotechnologies Co…Common Stock | 2026-10-06 | S sold | -499 | $30.53 | 377,802 | Form 4 |
| ADPT · Adaptive Biotechnologies Co…Stock Option (right to buy), derivative | 2026-10-06 | M exercised | -11,881 | $0 | 332,253 | Form 4 |
| Adaptive Biotechnologies Co… Common Stock | 2026-10-05 | M exercised | +11,881 | $12.14 | 389,683 | Form 4 |
| Adaptive Biotechnologies Co… Common Stock | 2026-10-05 | S sold | -6,699 | $28.82 | 382,984 | Form 4 |
| Adaptive Biotechnologies Co… Common Stock | 2026-10-05 | S sold | -5,182 | $29.67 | 377,802 | Form 4 |
| Adaptive Biotechnologies Co… Stock Option (right to buy), derivative | 2026-10-05 | M exercised | -11,881 | $0 | 344,134 | Form 4 |
| Adaptive Biotechnologies Co… Common Stock | 2026-10-02 | M exercised | +11,881 | $12.14 | 389,683 | Form 4 |
| Adaptive Biotechnologies Co… Common Stock | 2026-10-02 | S sold | -11,881 | $28.13 | 377,802 | Form 4 |
| Adaptive Biotechnologies Co… Stock Option (right to buy), derivative | 2026-10-02 | M exercised | -11,881 | $0 | 356,015 | Form 4 |
| Adaptive Biotechnologies Co… Common Stock | 2026-10-01 | M exercised | +11,881 | $12.14 | 389,683 | Form 4 |
| Adaptive Biotechnologies Co… Common Stock | 2026-10-01 | S sold | -6,081 | $27.57 | 383,602 | Form 4 |
| Adaptive Biotechnologies Co… Common Stock | 2026-10-01 | S sold | -5,800 | $28.56 | 377,802 | Form 4 |
| Adaptive Biotechnologies Co… Stock Option (right to buy), derivative | 2026-10-01 | M exercised | -11,881 | $0 | 367,896 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001780664-26-000037 | Adaptive Biotechnologies Corp | 2026-10-08 | ||
| Form 4 0001780664-26-000035 | Adaptive Biotechnologies Corp | 2026-10-05 |